We found that OSI treatment led to upregulation of MCT1 in CRC cells (Fig. 6a), but olmutinib failed to elevate the protein level of MCT1 (Supplementary Fig. 3G). The gene discussed is SLC16A1; the disease is colorectal carcinoma.